Literature DB >> 25130727

The effects of anakinra on focal cerebral ischemic injury in rats.

Yu-Ye Xia, Shu-Wei Song, Yang Min, Yan Zhong, Yu-Chen Sheng, Run-Ping Li, Quan-Hai Liu.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25130727      PMCID： PMC6493072          DOI： 10.1111/cns.12310

Source DB:  PubMed          Journal:  CNS Neurosci Ther        ISSN： 1755-5930            Impact factor:   5.243


× No keyword cloud information.
  8 in total

1.  Interleukin-1 influences ischemic brain damage in the mouse independently of the interleukin-1 type I receptor.

Authors:  Omar Touzani; Herve Boutin; Rosalind LeFeuvre; Lisa Parker; Andy Miller; Giamal Luheshi; Nancy Rothwell
Journal:  J Neurosci       Date:  2002-01-01       Impact factor: 6.167

2.  Anakinra, a recombinant human interleukin-1 receptor antagonist (r-metHuIL-1ra), in patients with rheumatoid arthritis: A large, international, multicenter, placebo-controlled trial.

Authors:  Roy M Fleischmann; Joy Schechtman; Ralph Bennett; Malcolm L Handel; Gerd-Rudiger Burmester; John Tesser; Dennis Modafferi; Jennifer Poulakos; Gordon Sun
Journal:  Arthritis Rheum       Date:  2003-04

Review 3.  Cytokines and the nervous system II: Actions and mechanisms of action.

Authors:  N J Rothwell; S J Hopkins
Journal:  Trends Neurosci       Date:  1995-03       Impact factor: 13.837

4.  E-selectin deficiency attenuates brain ischemia in mice.

Authors:  Xiu-Juan Ma; Jin-Wei Cheng; Jing Zhang; Ai-Jun Liu; Wei Liu; Wei Guo; Fu-Ming Shen; Guo-Cai Lu
Journal:  CNS Neurosci Ther       Date:  2012-09-17       Impact factor: 5.243

Review 5.  Regulation of interleukin-1 in acute brain injury.

Authors:  David Brough; Pippa J Tyrrell; Stuart M Allan
Journal:  Trends Pharmacol Sci       Date:  2011-07-23       Impact factor: 14.819

6.  Delayed administration of interleukin-1 receptor antagonist protects against transient cerebral ischaemia in the rat.

Authors:  Nicholas J Mulcahy; Jerard Ross; Nancy J Rothwell; Sarah A Loddick
Journal:  Br J Pharmacol       Date:  2003-08-26       Impact factor: 8.739

7.  Resolvin D1, an endogenous lipid mediator for inactivation of inflammation-related signaling pathways in microglial cells, prevents lipopolysaccharide-induced inflammatory responses.

Authors:  Min-Xuan Xu; Bing-Chang Tan; Wei Zhou; Ting Wei; Wei-Hong Lai; Jing-Wang Tan; Jia-Hong Dong
Journal:  CNS Neurosci Ther       Date:  2013-04       Impact factor: 5.243

8.  Fucoidan protects against lipopolysaccharide-induced rat neuronal damage and inhibits the production of proinflammatory mediators in primary microglia.

Authors:  Yan-Qiu Cui; Yan-Jun Jia; Ting Zhang; Quan-Bin Zhang; Xiao-Min Wang
Journal:  CNS Neurosci Ther       Date:  2012-10       Impact factor: 5.243
  8 in total
  3 in total

1.  Intranasal Administration of Interleukin-1 Receptor Antagonist in a Transient Focal Cerebral Ischemia Rat Model.

Authors:  Jae Hoon Lee; Eun Hee Kam; Jeong Min Kim; So Yeon Kim; Eun Jeong Kim; So Yeong Cheon; Bon-Nyeo Koo
Journal:  Biomol Ther (Seoul)       Date:  2017-03-01       Impact factor: 4.634

Review 2.  Systematic Review and Meta-Analysis of the Efficacy of Interleukin-1 Receptor Antagonist in Animal Models of Stroke: an Update.

Authors:  Sarah K McCann; Fala Cramond; Malcolm R Macleod; Emily S Sena
Journal:  Transl Stroke Res       Date:  2016-08-15       Impact factor: 6.829

Review 3.  Post-stroke inflammation-target or tool for therapy?

Authors:  Kate Lykke Lambertsen; Bente Finsen; Bettina Hjelm Clausen
Journal:  Acta Neuropathol       Date:  2018-11-27       Impact factor: 17.088
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.